Luminex Corp. Stock Rating Lowered by JPMorgan Chase & Co. (LMNX)
Luminex Corp. (NASDAQ:LMNX) was downgraded by investment analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating in a note issued to investors on Tuesday, TheFlyOnTheWall.com reports.
A number of other analysts have also recently weighed in on LMNX. Analysts at Zacks reiterated a “neutral” rating on shares of Luminex Corp. in a research note to investors on Friday, November 29th. They now have a $21.00 price target on the stock. Separately, analysts at Wedbush cut their price target on shares of Luminex Corp. from $19.00 to $18.00 in a research note to investors on Tuesday, November 5th. They now have a “neutral” rating on the stock. Finally, analysts at UBS AG cut their price target on shares of Luminex Corp. from $24.00 to $21.50 in a research note to investors on Tuesday, November 5th. They now have a “neutral” rating on the stock. Two research analysts have rated the stock with a sell rating and five have issued a hold rating to the company’s stock. Luminex Corp. presently has a consensus rating of “Hold” and an average price target of $20.13.
Shares of Luminex Corp. (NASDAQ:LMNX) traded up 0.05% during mid-day trading on Tuesday, hitting $18.33. 182,723 shares of the company’s stock traded hands. Luminex Corp. has a 52 week low of $15.39 and a 52 week high of $24.10. The stock’s 50-day moving average is $18.78 and its 200-day moving average is $20.0. The company has a market cap of $767.4 million and a P/E ratio of 119.74.
Luminex Corp. (NASDAQ:LMNX) last announced its earnings results on Monday, November 4th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.09. The company had revenue of $50.80 million for the quarter, compared to the consensus estimate of $54.67 million. During the same quarter in the previous year, the company posted $0.04 earnings per share. The company’s revenue for the quarter was up 1.6% on a year-over-year basis. Analysts expect that Luminex Corp. will post $0.14 EPS for the current fiscal year.
Luminex Corporation (NASDAQ:LMNX)develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.